2026
article
OpenAlex
Yvan Sinclair Ngaha Tchawe, Freddy Elad Essogmo, Ikenna Kingsley Uchendu, Abah Moses Owoicho et autres
BACKGROUND: Lung cancer remains the leading cause of cancer mortality worldwide, underscoring the need for non-invasive early diagnostic tools. IP-10, a cytokine involved in inflammation and angiogenesis, is a promising candidate. The present study aims to assess the relevance of IP-10 in …
ru
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Freddy Elad Essogmo, Angelina V. Zhilenkova, Yvan Sinclair Ngaha Tchawe, Abah Moses Owoicho et autres
Lung cancer is currently the second leading cause of cancer death worldwide. In recent years, checkpoint inhibitor immunotherapy (ICI) has emerged as a new treatment. A better understanding of the tumor microenvironment (TMJ) or the immune system surrounding the tumor is needed. …
ru, Cameroun
(code pays fourni par la source)
Accès ouvert
2023
preprint
OpenAlex
Ikenna Kingsley Uchendu, Yvan Sinclair Ngaha Tchawe, Zhilenkova Angelina V., Zaiana D. Sangadzhieva et autres
Renal cell carcinoma (RCC), alternative term for kidney cancer, is becoming more common worldwide each year, and there are many different contributing factors. Among all cancers, RCC is the 14th most prevalent; and it ranks as the 14th and 9th most prevalent …
Nigéria, ru, nl
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Angelina V. Zhilenkova, Freddy Elad Essogmo, Ikenna Kingsley Uchendu, Abah Moses Owoicho et autres
Research has shown the role of growth factors in lung cancer angiogenesis. Angiogenesis promotes lung cancer progression by stimulating tumor growth, enhancing tumor invasion, contributing to metastasis, and modifying immune system responses within the tumor microenvironment. As a result, new treatment techniques …
ru, ch, Nigéria, Cameroun
(code pays fourni par la source)
Accès ouvert
2023
preprint
OpenAlex
Yvan Sinclair Ngaha Tchawe, Zhilenkova Angelina V., Ikenna Kingsley Uchendu, Abah Moses Owoicho et autres
Research has shown the role of growth factors in lung cancer angiogenesis. Angiogenesis promotes lung cancer progression by stimulating tumor growth, enhancing tumor invasion, contributing to metastasis, and modifying immune system responses within the tumor microenvironment. As a result, new treatment techniques …
ru, nl, ch, Nigéria, Cameroun
(code pays fourni par la source)
Accès ouvert
2023
preprint
OpenAlex
Yvan Sinclair Ngaha Tchawe, Zhilenkova Angelina V., Ikenna Kingsley Uchendu, Abah Moses Owoicho et autres
Research has shown the role of growth factors in lung cancer angiogenesis. Angiogenesis promotes lung cancer progression by stimulating tumor growth, enhancing tumor invasion, contributing to metastasis, and modifying immune system responses within the tumor microenvironment. As a result, new treatment techniques …
ru, nl, ch, Nigéria, Cameroun
(code pays fourni par la source)
Accès ouvert
2023
preprint
OpenAlex
Freddy Elad Essogmo, Zhilenkova Angelina V., Abah Moses Owoicho, Yvan Sinclair Ngaha Tchawe et autres
Lung cancer accounts for the majority of cancer cases. In recent years, checkpoint inhibitor immunotherapy (ICI) has emerged as a new treatment. A better understanding of the tumor microenvironment, or TMJ, or the immune system surrounding the tumor is needed. Cytokines are …
ru, nl
(code pays fourni par la source)
2014
conference-abstract
OpenAlex
А. Л. Акопов, Alexander S. Rusanov, Nikita Kazakov, I. Chistiakov et autres
ru
(code pays fourni par la source)
Accès ouvert
2013
conference-abstract
OpenAlex
А. Л. Акопов, Alexander S. Rusanov, Ivan Chistyakov, Nikita Kazakov et autres
About one-third of NSCLC patients have unresectable locally advanced tumour or limited pulmonary function. Preoperative and intraoperative photodynamic therapy (PDT) was performed for the purpose of reducing the extent of resection in this type of patients. Twenty-two patients with central stage II-III …
ru
(code pays fourni par la source)
2013
article
OpenAlex
А. Л. Акопов, Alexander S. Rusanov, I. Chistiakov, Margarita Urtenova et autres
2011
conference-abstract
OpenAlex
Giulia Fabbri, Samuele Baldasseroni, Domenico Panuccio, Massimo Zoni Berisso et autres
Results: Out of 664159 women there were 22938 patients with hyperlipidaemia (3.5%) and 9312 patients with breast cancer. Out of the hyperlipidaemia patients, 530 patients developed breast cancer (2.3%) compared with 8782 patients developing breast cancer without hyperlipidaemia (1.4%). A logistic regression …